Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Benkowitz currently holds 7,875 shares of UNITED THERAPEUTICS Corp (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Benkowitz has been a net seller of UTHR stock. They have purchased $0 and sold $179.6M worth of shares.
Michael Benkowitz's most recent insider trade was on Dec 29, 2025, when they sold 14,625 shares at $502.79 per share.
Michael Benkowitz serves as Executive at UNITED THERAPEUTICS Corp (UTHR). They have executed 297 insider transactions totaling $179.6M over their tenure at the company.
Michael Benkowitz holds the position of Executive at UNITED THERAPEUTICS Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Michael Benkowitz has shown a selling trading pattern, with $0 in total purchases and $179.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael Benkowitz was on Dec 29, 2025, when they sold $7.4M worth of UTHR shares. This transaction involved 14,625 shares at $502.79 per share.
Michael Benkowitz currently owns 7,875 shares of UNITED THERAPEUTICS Corp (UTHR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Benkowitz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Benkowitz has 297 Form 4 filings on record as an insider at UNITED THERAPEUTICS Corp.
Set alerts for Michael Benkowitz and 40,000+ other insiders.